Search results
GenomesDAO Secures New Investment Round From Pantera Capital and Modular Capital
StreetInsider· 3 days agoBiotech company continues to gain momentum in its quest to revolutionize the decentralized genomics market. LONDON, UK / ACCESSWIRE / June 12, 2024 / GenomesDAO ...
This High-Flying Stock Just Announced More Good News: Time to Buy? | The Motley Fool
The Motley Fool· 6 days agoThe biotech industry features many prominent companies that command plenty of attention on the...
Will GSI Technology (NASDAQ:GSIT) Spend Its Cash Wisely?
Simply Wall St. via Yahoo Finance· 21 hours agoFor example, biotech and mining exploration companies often lose money for years before finding...
Foresite, a biotech venture firm, reloads with $900M fund
BioPharma Dive via Yahoo Finance· 3 days agoAmid some optimism for biotech startups, the firm sees opportunities to fund companies “at all...
Why Moderna Stock Is a No-Brainer Buy Right Now | The Motley Fool
The Motley Fool· 5 days agoIn 2022, the biotech company generated sales of nearly $18.9 billion, but it expects revenue of only...
We're Keeping An Eye On Adicet Bio's (NASDAQ:ACET) Cash Burn Rate
Simply Wall St. via Yahoo Finance· 5 days agoWe can readily understand why investors are attracted to unprofitable companies. For example, ...
East Bay startup scores $125 million to target one of biotech's hottest areas - San Francisco...
The Business Journals· 1 day agoAn Alameda biotech startup landed a $125 million round to target a range autoimmune and inflammatory...
TEM Stock IPO: 7 Things to Know as Tempus AI Starts Trading Today
InvestorPlace· 17 hours agoOne of the season’s most highly anticipated initial public offerings (IPOs) is taking place today....
4Moving Biotech announces successful results from its Lasare Phase I 4P004 Clinical Trial...
Benzinga· 5 days agoLasare Phase I clinical trial demonstrated acceptable safety and tolerability profiles of 4P004 intra-articular liraglutide for treating knee osteoarthritis 4Moving Biotech received constructive pre-IND guidance
Amid big Bayer shakeup, drugmaker loses Berkeley-based biotech chief - San Francisco Business Times
The Business Journals· 4 days agoJens Vogel, who as global head of biotech led Bayer AG's push into cell therapy manufacturing from...